Key result
Newly diagnosed essential hypertension linked to ~120% higher microalbuminuria prevalence versus normotensive controls.
Why the study?
Microalbuminuria is an early marker of kidney damage and predicts cardiovascular and end-stage renal disease, making its assessment important to reduce morbidity and mortality in hypertensive patients.
Is newly diagnosed essential hypertension associated with an increased frequency of microalbuminuria compared to normotensive individuals?
Population
85 newly diagnosed essential hypertension patients and 415 normotensive participants aged 25 to 65 years
Comparison
Newly diagnosed essential hypertension vs normotensive participants
Design
Cross-sectional hospital analytic study
Authors
Loading...
May support microalbuminuria screening at hypertension diagnosis; extends cross-sectional links but leaves causal and prognostic value open.
Cross-Sectional (n=500)
No
Is newly diagnosed essential hypertension associated with an increased frequency of microalbuminuria compared to normotensive individuals?
Absolute Event Rate: 28.8% vs 13.1%
p-value: p=0.000
Newly diagnosed essential hypertension is strongly associated with microalbuminuria and macroalbuminuria, highlighting the need for early renal and cardiovascular risk assessment in these patients.
Khairallah et al. (2019) conducted a cross-sectional in Essential hypertension (n=500). Essential hypertension vs. Normotensive healthy participants was evaluated on Microalbuminuria (p=0.000). Newly diagnosed essential hypertension was associated with a significantly higher prevalence of microalbuminuria compared to normotensive controls (28.8% vs 13.1%; P=0.000).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: